Survival of patients receiving a liver transplant for hepatocellular carcinoma, and risk of tumor recurrence;Supervivencia del paciente trasplantado de hígado por hepatocarcinoma y riesgo de recurrencia tumoral

Revista Espanola de Enfermedades Digestivas

Volumn 98, Issue 12, 2006, Pages 899-906

  Pérez De Luque, Daniel ^a,b   Lopez Vallejos P ^a   Montero Alvarez J L ^a   Fraga Rivas, E ^a   Barrera Baena, P ^a   Costan Rodero G ^a   Rufian Pena S ^a   Diaz Iglesias C ^a   Lopez Cillero P ^a   Briceno Delgado J ^a   Padillo Ruiz, J ^a   Pozo Laderas, J C ^a   Marchal Molina, T ^a   Solorzano Peck G ^a   De La Mata Garcia M ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b NONE   (Ecuador)

Author keywords

Hepatocellular carcinoma; Incidental tumors; Liver transplant; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; TREATMENT RESPONSE; CANCER STAGING; LIVER TUMOR; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; RISK; SPAIN; SURVIVAL; SURVIVAL RATE; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK; SPAIN; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34248523357     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082006001200002     Document Type: Article

References (30)

1. Bosch FX, Ribes J, Cleries R, Díaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9 (2): 191-211.
2. Arii S, Yamaoka Y, Futagawa S, Inocue K, Kobayashi K, Kojiro M, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 2000; 32: 1224-9.
3. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 39: 1434-40.
4. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Christensen E, et al. Clinical management on hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001; 35: 421-30.
5. Varela M, Sanchez W, Bruix J, Gores GJ. Hepatocellular carcinoma in the setting of liver transplantation. Liver Transp 2006; 12: 1028-36.
6. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42 (5): 1208-36.
7. Calleja Kempin J, Colón Rodríguez A, Muro de la Fuente A, Clemente Ricote G, Prieto Martín M, Santos Castro L, et al. Tumoral response factors after radiofrequency ablation of hepatocellular carcinoma in cirrhotic liver. Rev Esp Enferm Dig 2005; 97 (10): 688-98.
8. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37 (2): 429-42.
9. Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl 2003; 9 (7): 684-92.
10. Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, et al. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transpl 2004; 10 (12): 1478-86.
11. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334 (11): 693-9.
12. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218 (2): 145-51.
13. Martínez Ares D, Suárez López FJ, Souo Ruzo J, Otero Ferreiro A, Gómez Gutiérrez M, González Conde C, et al. Liver transplantation in patients with hepatocellular carcinoma: factors implicated in tumor relapse. Rev Esp Enferm Dig 2004; 96: 22-31.
14. Chevret S, Trinchet JC, Mathiu D, Rached AA, Beaugrand M, Chastang C. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol 1999; 31: 133-41.
15. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16: 132-7.
16. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso MC, Sala M, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29: 62-7.
17. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270-85.
18. Moreno P, Jaurrieta E, Figueras J, Benasco C, Rafecas A, Fabregat J, et al. Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma?. Transplant Proc 1995; 27: 2296-8.
19. Pérez Saborido B, Loinaz Segurola C, Gimeno Calvo A, Meneu Díaz JC, Abradelo de Usera M, Calvo Pulido J, et al. Liver transplantation for hepatocellular carcinoma: our experience from 1986. Transplant Proc 2003; 35 (5): 1825-6.
20. Cho CS, Knechtle SJ, Heisey DM, Hermina M, Armbrust M, D'Alessandro AM, et al. Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma. J Gastrointest Surg 2001; 5 (6): 594-601.
21. González-Uriarte J, Valdivieso A, Gastaca M, Errasti G, Campo M, Hernández MJ, et al. Liver transplantation for hepatocellular carcinoma in cirrhotic patients. Transplant Proc 2003; 35 (5): 1827-9.
22. Ackhar JP, Araya V, Baron RL, Marsh JW, Dvorchik I, Rakela J. Undetected hepatocellular carcinoma: clinical features and outcome after liver transplantation. Liver Transpl Surg 1998; 4 (6): 477-82.
23. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998; 228 (4): 479-90.
24. Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000; 191 (4): 389-94.
25. Tamura S, Kato T, Berho M, Misiakos EP, O'Brien C, Reddy Kr, et al. Impact of histologic grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 2001; 136: 25-30.
26. Chau GY, Lui WY, Wu CW. Spectrum and significance of microscopic vascular invasion in hepatocellular carcinoma. Surg Oncol Clin N Am 2003; 12 (1): 25-34.
27. Salizzoni M, Romagnoli R, Lupo F, David E, Mirabella S, Cerutti E, et al. Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation. Transplantation. 2003; 76 (5): 844-8.
28. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004; 10 (4): 534-40.
29. Grasso A, Stigliano R, Morisco F, Martines H, Quaglia A, Dhillon AP, et al. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation 2006; 81 (11): 1532-41.
30. Frilling A, Malago M, Broelsch CE. Current status of liver transplantation for treatment of hepatocellular carcinoma. Dig Dis 2001; 19 (4): 333-7.